Breaking News
Top News
-
Annexon Biosciences (ANNX) Buy Rating Retained
-
You Delivered That Load Three Weeks Ago. Here Is Why You Still Do Not Have the Money — and What to Do About It.
-
Compass Therapeutics, Inc. (CMPX) Up 200% Year-on-Year
-
American International Group Earnings Preview: What to Expect
-
Intellia Therapeutics, Inc. (NTLA) Sees Moderate Buy Rating From Analysts
-
Iran War Has Cost The World $50 Billion of Lost Oil Supply, So Far
-
Euro Falls After Weaker German PMI Data
-
Shares of Apple Supplier STMicroelectronics Jump After Strong Quarter
-
Pension VBL Moves €2 Billion Housing Portfolio to Fund
-
France Probes Weather Data Tampering After Surge in Polymarket Bets
-
Insight with Haslinda Amin 4/23/2026
-
German Business Activity Unexpectedly Shrinks as Services Plunge
-
Tesla Supplier Yangzhou Nanopore Is Said to File for Hong Kong IPO
-
Euro-Zone Private Sector Unexpectedly Shrinks as Services Slump
-
Odd Lots: Google’s Liz Reid on Search in an AI World (Podcast)
-
Google’s Liz Reid on Who Will Own Search in a World of AI
-
Iconic seafood chain brings back controversial meal deal
-
Tesla Is Ramping Up Hiring for Its Taiwan Terafab. Does That Make TSLA Stock a Buy Now?
-
GLOBALFOUNDRIES (GFS) Lands A Strategic Role In Apple’s Next Semiconductor Push
-
Credo Technology Group (CRDO): A $210 Target Signals Something Bigger Is Building
2026-02-05


































